EpiKare Bio brings together expertise in epithelial and stromal biology, drug discovery and clinical dermatology, supported by advisors with experience in biotechnology development and business strategy.
Leadership
Prof. Gian-Paolo Dotto
Co-founder, Chairman of the Board & Executive Leadership
Harvard Medical School /Massachusetts General Hospital
Prof. Reinhard Dummer
Board Member
University of Zürich
Dr. An Buckinx
Co-founder & Chief Operating Officer
Prof. Christopher Buckley
Director of Translational Strategy
University of Oxford
Co-founder of Mestag Therapeutics
Scientific Advisory Board
Prof. Angela Koehler
Broad Institute/MIT, Entrepreneurial experience includes Ligon Discovery, Kronos Bio, 76Bio and Samori Bio
Prof. Daniel Hohl
University of Lausanne
Expertise in dermatopathology, skin cancer prevention and early detection
Prof. Anna Mandinova
Massachusetts General Hospital
Entrepreneurial experience includes SeylanMED, New Frontier Bio and Clover Key Bioscience
Prof. Mitch Levesque
University of Zürich, Entrepreneurial experience includes Oncobit
Business Advisors
Dr. Matthias Schäfer
CEO, Topadur Pharma
Beata Gutman Krivoshey
Experience with Grasshopper, Humankind Capital and Correspondent Productions
Dr. Rajwinder Lehal
Experience with Cellestia Biotech and Viventis Microscopy
Connect with EpiKare Bio
Interested in our science or exploring a potential collaboration? We welcome enquiries from researchers, development partners and investors.
